Navigo Proteins

Navigo Proteins Announces Strategic R&D Collaboration with SCK CEN to Develop Targeted Radiotheranostics

1 April 2025 -- Halle, Germany and Mol, Belgium -- Navigo Proteins GmbH, a leader in precision medicine and next-generation radiotheranostics, today announced a strategic research collaboration with SCK CEN, the Belgian Nuclear Research Centre. This partnership will focus on the preclinical development of next-generation radiotheranostics, using the Auger-electron emitting radioisotope Terbium (161Tb). This collaboration...
Heinrich-Damerow-Strasse 1 06120 Halle Germany

+49 345 27996-330